| 摘要 |
Compounds of the general formula I <IMG> I wherein R1 is C1-24 alkyl; C2-24 alkenyl; C2-24 alkynyl; tri(C1-4 alkyl)silylethyl; aryl optionally substituted with hydroxy, amino, C1-4 alkyl, C1-4 alkoxy, nitro, halogen, or phenoxy; mono- or di-halogen-C1-4alkyl; phenyl-C1-4alkyl; a group of the formula II or IIa R3-(CH2)n-S(O)m-CH2CH2- II R3-(CH2)n-S(O)m-CH2)2CH-CH2- IIa wherein R3 is H, carboxy, carboxy-C1-4 alkyl, hydroxy, amino, or a carrier, n is an integer from 1 to 24, and m is 0 or 2; a group of the formula III or IIIa Phe-S(O)m-CH2CH2- III (Phe-S(O)m-CH2)2CH-CH2- IIIa wherein m is as defined above, and each Phe is a phenyl group optionally monosubstituted with hydroxy, amino, C1-4 alkyl, C1-4 alkoxy, nitro, halogen, or phenoxy a group of the formula IV R4CH2CH(CH2R5)CH2- IV wherein R4 and R5 independently are halogen; a group Q-(CH2)n- where Q is a carrier, and n is as defined above; and R2 is a mono- or disaccharide moiety connected via a glycosidic bond; C1-18 alkyl; C2-18 alkenyl; C2-18 alkynyl; C1-18 alkyloxymethyl; C1-18 alkanoyl; .alpha.-hydroxy-C1-18 alkanoyl; naphthyl-, heterocyclyl- or phenyl-C1-8 alkoxy where the naphthyl, heterocyclyl or phenyl group may be substituted with hydroxy, amino, C1-4 alkyl, C1-4 alkoxy, nitro, halogen, or phenoxy; tri(C1-4-alkyl)silylethyl; tri(C1-4-alkyl)silyl; tri(C1-4-alkyl)silylet-hoxymethyl; halogen; .omega.-hydroxy-C1-4alkyl; tetrahydropyranyl; benzyloxymethyl; C3-8 cycloalkyl; a monoterpenyl moiety; benzoyl optionally monosubstituted with hydroxy, amino, C1-4 alkyl, C1-4 alkoxy, nitro, halogen, or phenoxy; the acyl residue of a naturally occurring amino acid; or a group of the formula V R6-C(O)-N(R7)-CH(R8)-CH2- V wherein R6 is C1-4 alkyl; or phenyl optionally monosubstituted with hydroxy, amino, C1-4 alkyl, C1-4 alkoxy, nitro, halogen, or phenoxy, R7 is H or C1-4 alkyl, and R8 is H, C1-4 alkyl, or hydroxy-C1-4 alkyl, Z is -O-, -S-, -SO2-, or -CH2-, X is -O-, -S-, -SO2-, -CH2-, or -NR3-, wherein R3 is H or is one of the meanings for R2 above, R3 and R1 optionally being connected to form a ring, and Y is -O- or -NR3- where R3 is H or is one of the meanings for R2 above, R3 and R2 optionally being connected to form a ring, as well as diagnostic devices or kits comprising at least one of such compounds in substantially immobilized form, and pharmaceutical compositions comprising at least one of the compounds in combination with a pharmaceutically acceptable inert carrier. Compounds of the general formula I have enhanced receptor binding properties to bacteria and are useful in inhibiting the binding of bacteria to mammalian cell surfaces.
|
